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Ebola superspreading
Ousmane Faye and colleagues 1 recently described the chains of transmission for 152 individuals infected with Ebola virus diseases in Guinea. The resulting transmission trees provide unique insights into the individual variation in the number of secondary cases generated by an infected index case. A better understanding of this variation provides crucial information about epidemic spread, the expected number of superspreading events, and the eff ects of control measures. 2 The number of secondary cases in the transmission trees is highly skewed, with 72% of individuals not generating further cases (fi gure). Fitting a negative binomial distribution to the data (appendix) provides maximumlikelihood esti mates of the mean (0·95, 95% CI 0·57-1·34) and the dispersion parameter (k=0·18, 95% CI 0·10-0·26). The mean corresponds to the basic reproduction number (R 0 ) of the overall population. The estimated value of k, which is substantially smaller than 1, sug gests that the distribution of the individual reproduction number is highly overdispersed. 2 The value for Ebola virus disease is similar to that estimated for severe acute respiratory syndrome (k=0·16). 2 This finding suggests that superspreading events for Ebola virus disease are an expected feature of the individual variation in infectiousness. 3 I simulated stochastic trajectories of Ebola virus disease outbreaks starting from one infected index case (fi gure). To this end, I drew the number of secondary cases for each case from the fitted negative binomial distribution (appendix). The time from disease onset in one case to disease onset in the next case was drawn from the reported gamma-distributed serial interval with a mean duration of 15·3 days. 4 Although most outbreaks rapidly become extinct, some epidemic trajectories can reach to more than 100 infected cases. This finding is particularly remarkable because R 0 is less than 1, and shows the potential for explosive outbreaks of Ebola virus disease.
R 0 during the early phase of the Ebola virus disease epidemic in Guinea has been estimated to be roughly 1·5. 5 The transmission trees from Faye and colleagues were generated from data obtained between February and August, 2014, when the reproduction number was fl uctuating around unity. 1, 4 That scenario is similar to the present situation in parts of west Africa where the incidence is declining but new outbreaks still occur. The observed variation in individual infectiousness for Ebola virus disease means that although the probability of extinction is high, new index cases also have the potential for explosive regrowth of the epidemic. I received funding through an Ambizione grant from the Swiss National Science Foundation (project 136737). I declare no competing interests. 
Christian L Althaus
Norovirus in patients with gastroenteritis
In a comprehensive and updated systematic review and meta-analysis, Sharia Ahmed and colleagues 1 assessed the role of norovirus as a cause of endemic acute gastroenteritis worldwide. In their pooled analysis of 175 studies, noroviruses were detected in 18% of patients with acute gastroenteritis: 24% in the community, 20% in outpatients, and 17% in inpatients. 1 Identifi cation of the causal role of noroviruses in acute gastroenteritis is very important, in view of the possibility of shifting patterns of causal agents of acute gastroenteritis in some regions, characterised by a decreasing proportion of bacterial enteropathogens and the emergent role of enteric viruses. 2 We do not know whether the introduction of rotavirus immunisation in many regions, with a subsequent substantial reduction in cases of rotavirus diarrhoea, 3 will lead to the replacement of rotavirus by other agents (eg, norovirus) as the leading cause of paediatric diarrhoea. Thus, findings such as those reported by Ahmed and colleagues 1 are valuable for the monitoring of changes in the cause of diarrhoeal diseases and to set public health priorities.
Nonetheless, norovirus is detected in high proportions of asymptomatic people, as a result of truly asymp tomatic infections or shedding after a gastroenteritis episode. 4 Further more, in children residing in developing countries, mixed enteric infections are very common in both sick and healthy people. Therefore, because the assessment by Ahmed and colleagues 1 did not account for the background level of norovirus infection-ie, in patients without diarrhoea-and the presence of other enteric pathogens in the same stool specimen, it might have overestimated the causal role of norovirus in endemic gastroenteritis.
Last, norovirus genotypes might vary between endemic and epidemic gastroenteritis. All norovirus outbreaks in adults in Israel between 2003 and 2014 were caused by genotype GII.4. Sporadic cases in adults were under-reported. Outbreaks in adults were almost exclusively associated with closed settings (eg, old age or extended care facilities) and norovirus-positive cases were diagnosed in patients, staff , and, in some cases, families of staff. By contrast, endemic cases in children younger than 5 years admitted to hospital 5 included six genotypes in addition to GII.4. This genotypedependent and age-dependent epidemiological difference and underdiagnosis and under-reporting of sporadic adult cases of norovirus gastroenteritis would also aff ect the burden estimates of norovirus illness.
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